CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to PHM.MC

Obicetrapib

Phase 3
PharmaMar, S.A. (PHM.MC)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Nov '26
NAMSPhase 3

Obicetrapib Phase 3 Est. Readout (PREVAIL)

Obicetrapib
Nov 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Atherosclerotic Cardiovascular Disease

View Full Landscape
Drug Information

Target Indication

Atherosclerotic Cardiovascular Disease

Clinical Trial

NCT05202509

Last updated: 7/9/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.